|

Media
Contact:
Rod Schecter
Public Relations Director
Foundation for Cancer Research & Education
434.974.1303 ext 2
ebronis@earthlink.net
For
Immediate Release:
National
Conference on Prostate Cancer 2005 in the Nation's Capital:
Endorsement from Colin Powell
Charlottesville,
VA, March 24, 2005: The Foundation For Cancer Research & Education
(FCRE) and Us Too International
are proud to announce the National Conference on Prostate Cancer
2005: Exploring New Pathways - Sharing the Journey, June 16-19
at the Omni Shoreham Hotel in Washington, DC. Moderated by world-renowned
oncologist and prostate cancer survivor Dr. Charles "Snuffy"
Myers, the National Conference on Prostate Cancer 2005 promises
to be an indispensable resource for prostate cancer patients,
their loved ones, and savvy health professionals.
With
an endorsed personal narrative from former
Secretary of State and prostate cancer survivor Colin Powell to
be read during the meeting, the National Conference on Prostate
Cancer 2005 also hopes to increase prostate cancer awareness by
putting a powerful face on this disease.
"In
any military or other vital campaign, power comes from knowledge
or vigilance," says Powell. "This is especially true
in the protracted war against prostate cancer."
The
National Conferences on Prostate Cancer were created to give a
voice to men with this disease, but, more importantly, to provide
men with the vital educational tools to help them live longer
and improve the quality of their lives. With over twenty experts
on the agenda this three and a half day conference offers vital
information and support to patients at any stage of the disease,
as well as to health professionals wishing to explore the ins
and outs of treating it. In addition, Us TOO support group leaders
will be creating "caring and information sharing" opportunities
during the conference to allow patients and their loved ones to
become familiar with support groups and the benefit they can have
on quality of life for both men and their family members.
With
diverse topics ranging from the uPM3 test for diagnosing prostate
cancer to the use of Combidex MRI to locate cancer in lymph nodes,
this conference will provide the most cutting-edge information
available on all of the issues facing today's prostate cancer
patient.
"Nowhere
else can you get this much information from so many reliable sources,"
says Dr. Myers. "And nowhere else can you share in the supportive
energy of so many survivors. Whether you've just been diagnosed
or are suffering from treatment side effects, this is THE conference
to attend."
To
support early detection and advocacy, the National Conference
on Prostate Cancer 2005 will also make free PSA tests available
to both conference participants and community residents who do
not attend. Despite the controversy over this test, there is a
large consensus that believes early prostate cancer detection
means more treatment options and higher success rates.
Prostate
cancer is now the most commonly diagnosed cancer in American men.
Recent statistics from the American Cancer Society estimate that
there will be approximately 232,090 new cases of prostate cancer
in the United States in 2005 and that 30,350 men will die of this
disease-that's one death every 17.5 minutes. However, prostate
cancer is highly treatable and recent advances are consistently
proving that a prostate cancer diagnosis is not a death sentence.
While
many of the newest treatments are highly effective, there is still
no cure. It is a sad truth, however, that many men remain unaware
of the treatment options available to them. All of the participants
in this conference sincerely believe that is only through excellence
in education that patients get the information they desperately
need to become empowered and ultimately survive. Registration
for the National Conference on Prostate Cancer 2005 is $50 per
person until April 15 and $75 thereafter. For conference details
or to register or call 310-743-2117.
On
the value of this conference, participating radiation oncologist
Dr. Michael Dattoli adds, "Having learned the lessons of
those before him, it is the informed patient who is most likely
to beat the cancer odds."
###
The
Foundation for Cancer Research and Education (FCRE) is dedicated
to educating cancer patients about prevention and treatment in
the context of their overall health. With science based on the
most well designed research protocols, FCRE's goal is to prolong
patients' lives by making them active participants in their own
treatment. For more information or for a list of FCRE's outreach
programs call 800-305-2432 or go to www.cancer-foundation.org.
Us
TOO is a not-for-profit organization providing information, counseling
and educational meetings to assist men with prostate disease (and
their spouses / partners) in making decisions about their treatment
with confidence and support. Us TOO chapter meetings are free
and open to newly diagnosed patients, patients currently in their
treatment regimen, survivors, family members, friends and healthcare
professionals interested in prostate disease. For questions go
to 800-808-7866 or log on at www.ustoo.org
Click
here for the print version of the release
|